Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Two-drug HIV backbone and daily HIV prevention pill (PrEP). | Backbone drug for HIV treatment, PrEP and hepatitis B. |
| Body system | Antivirals | Antivirals |
| Drug class | Nucleos(t)ide reverse transcriptase inhibitors | Nucleos(t)ide reverse transcriptase inhibitors |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | HIV pre-exposure prophylaxis, HIV infection (with a third drug), Post-exposure prophylaxis (with a third drug) | HIV treatment, HIV pre-exposure prophylaxis (PrEP, with emtricitabine), Chronic hepatitis B |
| How it works | Blocks HIV from copying itself, in treatment or prevention. | A fake DNA building block that stops HIV and hepatitis B copying themselves. |
| Starts working | PrEP: protection builds over 7–20 days | — |
| Half-life | Emtricitabine about 10 hours; tenofovir about 17 hours (intracellular days) | About 17 hours in plasma |
| Typical adult dose | One tablet (emtricitabine 200 mg/tenofovir disoproxil 300 mg) once a day. | 300 mg (245 mg tenofovir disoproxil) once a day. |
| Forms | Tablet | Tablet, Combination tablets |
| Common side effects | Nausea, Headache, Diarrhoea, Tiredness | Nausea, Diarrhoea, Headache, Dizziness |
| Serious side effects | Kidney problems, Bone density loss, Hepatitis B flare on stopping, Lactic acidosis (rare) | Kidney damage, Bone thinning, Hepatitis B flare if stopped suddenly |
| Don't take if | Unknown HIV status for PrEP (test first); Creatinine clearance under 30 mL/min; Taking lamivudine | — |
| Alcohol | Best to limit. Alcohol adds to liver and kidney strain. | — |
| Pregnancy | Generally considered safeUsed in pregnancy for HIV treatment and PrEP. | Generally considered safeWidely used in pregnancy for HIV and hepatitis B. |
| Breastfeeding | Use with cautionPasses into milk in small amounts; consult your clinic. | — |
| In use since | — | 2001 |
| Brand names | United States: Truvada, DescovyUnited Kingdom: TruvadaIndia: Truvada, Tenvir-EM | United States: Viread, Truvada (with emtricitabine)United Kingdom: Viread, TruvadaIndia: Tenvir |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | J05AR03 | J05AF07 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker